Robert Church
FDA Shows that it Means Business in Stopping Stem Cell Clinics that Put Patients at Risk
Focus on Regulation ·
FDA Weighs In on When Pregnant Patients Should be Included in Clinical Trials
Focus on Regulation ·
FDA Issues Draft Guidance on Requirements for Public Warnings for Recalled Products
Focus on Regulation ·